Skip to main content
Clinical Trials/NCT01844557
NCT01844557
Unknown
Not Applicable

Testing Accountability in Patient Adherence

M.D. Anderson Cancer Center1 site in 1 country225 target enrollmentMay 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Head And Neck Cancer
Sponsor
M.D. Anderson Cancer Center
Enrollment
225
Locations
1
Primary Endpoint
Adherence to Swallowing Exercises
Last Updated
6 years ago

Overview

Brief Summary

The goal of this research study is to look for factors that influence whether or not head and neck cancer patients follow the swallowing exercises that they are asked to perform while receiving radiation treatment.

Detailed Description

Head and neck cancer patients who receive radiation are at risk for permanent swallowing disorders. Because of these potential problems, swallowing exercises are an important part of recovery. Researchers want to learn what factors affect how well patients follow the swallowing schedule they are given, and what can be done to make it consistent. If you agree to take part in this study, you will have the following procedures performed. Videotaped Swallowing Exercise: Researchers will ask you to perform 3 swallowing exercises while being recorded by a video camera. The length of the taping session will be 3 minutes. Afterward, you will fill out 3 questionnaires. The questionnaires will take about 10 minutes to complete. Length of Study: You will be asked to come in 1 time for this study. For the next 2 years, information may be collected from your medical record. This information will include the cancer stage, if the disease has gotten worse, any treatment you receive, and any side effects you experience. This information will help researchers learn how certain treatments affect patients and their risk for future disease. This is an investigational study. Up to 225 patient will take part in this study. All will be enrolled at MD Anderson.

Registry
clinicaltrials.gov
Start Date
May 2013
End Date
December 2021
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Are dispositioned to receive radiation with curative intent for nasopharyngeal, oropharyngeal, hypopharyngeal, laryngeal, or an unknown primary cancer with cervical metastases.
  • Are stage II-IVB for oropharyngeal and laryngeal
  • Are stage I-IVB for hypopharyngeal and nasopharyngeal
  • At least 18 years of age
  • Speak and read English
  • Oriented to time, person, and place
  • Have a Zubrod performance status of 0 to 2

Exclusion Criteria

  • Have other cancer diagnoses, except non-melanoma skin cancer
  • Had treatment for previous H \& N cancer or radiation to the head and neck
  • Have a history of previous head and neck surgery (excluding biopsy and/or tonsillectomy and/or tracheotomy)
  • Have a current oropharyngeal dysphagia unrelated to cancer diagnosis (e.g., dysphagia due to underlying neurogenic disorder)

Outcomes

Primary Outcomes

Adherence to Swallowing Exercises

Time Frame: 1 day

Purpose of experiment is to determine whether an accountability manipulation and whether human vs technological monitoring result in higher patient adherence. Main outcome measure is perseverance of effort which will be number of repetitions within one minute interval for each exercise.

Study Sites (1)

Loading locations...

Similar Trials

Completed
Phase 4
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1%Acne
NCT00437151Galderma R&D61
Completed
Not Applicable
ADHEPTA Study: Adherence Questionnaire in Hepatitis CHepatitis C, ChronicHIV Infection
NCT00998621Fundacion IMIM1,120
Recruiting
Not Applicable
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck CancerCarcinoma of Unknown PrimaryClinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Metastatic Head and Neck CarcinomaMetastatic Malignant Neoplasm in the Uterine CervixPathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Pathologic Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Stage I Hypopharyngeal Carcinoma AJCC v8Stage I Nasopharyngeal Carcinoma AJCC v8Stage II Hypopharyngeal Carcinoma AJCC v8Stage II Laryngeal Cancer AJCC v8Stage II Nasopharyngeal Carcinoma AJCC v8Stage II Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage III Hypopharyngeal Carcinoma AJCC v8Stage III Laryngeal Cancer AJCC v8Stage III Nasopharyngeal Carcinoma AJCC v8Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage IV Hypopharyngeal Carcinoma AJCC v8Stage IV Laryngeal Cancer AJCC v8Stage IV Nasopharyngeal Carcinoma AJCC v8Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage IVA Hypopharyngeal Carcinoma AJCC v8Stage IVA Laryngeal Cancer AJCC v8Stage IVA Nasopharyngeal Carcinoma AJCC v8Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8Stage IVB Hypopharyngeal Carcinoma AJCC v8Stage IVB Laryngeal Cancer AJCC v8Stage IVB Nasopharyngeal Carcinoma AJCC v8Stage IVB Oropharyngeal (p16-Negative) Carcinoma AJCC v8
NCT03010150M.D. Anderson Cancer Center471
Terminated
Not Applicable
Evaluation of the Adherence and the Patient Acceptability of Zomacton® Treatment With the Zomajet® Vision X DeviceGrowth Hormone DeficiencyTurner's Syndrome
NCT02018172Ferring Pharmaceuticals3
Completed
Not Applicable
Development of a Marker of Adherence for Tracking Consumption of Nutrient SupplementsAdherence, Treatment
NCT04040543University of California, Davis50